Treatment of Peritrapezial Osteoarthritis With Isolated Trapeziometacarpal Arthroplasty in 300 Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorClinique Saint Jean, France

About this trial

The aim of this clinical trial is to assess the functional outcomes of isolated trapeziometacarpal joint arthroplasty in adult patients requiring surgical management of trapeziometacarpal osteoarthritis, with or without associated symptoms.

The primary endpoint is the evolution of the Quick DASH functional score between inclusion (preoperative) and one year postoperatively.

The study design is a follow-up study of a multicenter cohort.

Eligibility criteria

Qualifiers

Patients over 18 years of age who are members or beneficiaries of french social security

Patient requiring surgical management

TM (Eaton-Littler stages II to III) and STT (Crosby stages II and III) radiographic osteoarthritis

Persistent pain and functional limitations despite conservative treatment for at least 6 months (combining intermittent immobilization of wrist and thumb + joint infiltration of the 2 joints)

Disqualifiers

History of surgery on the affected thumb.

Systemic inflammatory diseases (e.g. rheumatoid arthritis).

Active infection or history of joint infection of the upper limb.

Inability to participate in post-operative follow-up.

Trial design

Treatments tested in this trial

  • Isolated trapeziometacarpal arthroplasty with double mobility

Treatment groups

300 Participants
are divided into 1 treatment group

Sponsors and collaborators